临床癌症研究(Clinical Cancer Research)是一本由American Association for Cancer Research Inc.出版的一本医学-肿瘤学学术刊物,主要报道医学-肿瘤学相关领域研究成果与实践。本刊已入选来源期刊,属于国际一流期刊。该刊创刊于1995年,出版周期Semimonthly。2021-2022年最新版WOS分区等级:Q1,2023年发布的影响因子为10,Cite...
YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)11.424524723 202211.3-23458 202112.658-21000 202011.16125116717 20197.0684719316 20185.6463136309 20176.2171865661 20165.1891814593 20154.3571553723 20144.4291073370 20133.2711042670 20123.0661002263
JCO CCI is an online-only interdisciplinary journal publishing clinically relevant research based on biomedical informatics methods and processes applied to cancer-related data, information, and images. 20192020202120222023Cancer ResearchHealth InformaticsOncology The set of journals have been ranked according t...
Cancer research (52.65%) Apoptosis (21.76%) Internal medicine (19.38%) What are the most cited papers published in the journal? Apoptosis in cancer: from pathogenesis to treatment (1268 citations) Health-related quality of life in breast cancer patients: A bibliographic review of the literature ...
and treatment of colorectal cancer and other Gastrointestinal Malignancies including pancreas, liver and esophageal cancer.Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators...
2 January 2023 View all announcements More opportunities to publish your research: Browse open Calls for Papers Advances in Imaging for Oncology Edited byDr Thankamma Ajithkumar,Dr Arumugam Rajesh August 2024 Function Preservation with Brachytherapy: Reviving the Art ...
“”We employed radiomics and clinical features to develop and validate a preoperative prediction model to estimate the omental metastases status of locally advanced gastric cancer (LAGC). A total of 460 patients (training cohort, n = 250; test cohort, n = 106; validation cohort, n...
Function Preservation with Brachytherapy: Reviving the Art Edited byAgata Rembielak,Ashwini Budrukkar,Tomas Kron August 2023 Multi-Modality Management of Early Rectal Cancer Edited byA.S. Myint,J.-P. Gerard February 2023 Abstracts from RCR 2022 November 2022...
Advanced non-small-cell lung cancer (NSCLC) patients with EGFR T790M-positive tumours benefit from osimertinib, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI). Here we show that the size of the EGFR T790M-positive clone impacts response to osimertinib. T790M subclonality,...
Impact Factor:1.781 (2023-24) Ingress Full textAuthor GuidelinesSubmit Your PaperOpen AccessPropose Special IssueRecommend to LibrarianEditor RegistrationsIndexing & ArchivingOrder ReprintsPay Online Pubmed Indexed Articles Journal of Pharmacology & Clinical Research is an internationally accepted, peer reviewe...